Advanced search
Publication Cover
The Journal of Maternal-Fetal & Neonatal Medicine Volume 29, 2016 - Issue 5
Submit an article Journal homepage
337
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Intravenous carbetocin shot is superior to oxytocin infusion for placental delivery in second trimester abortion: a pilot randomized controlled trial

Mohammed S. E. ElsaftyFaculty of Medicine, Department of Obstetrics and Gynecology, Ain Shams University, Cairo, Egypt
,
Alaa S. HassaninFaculty of Medicine, Department of Obstetrics and Gynecology, Ain Shams University, Cairo, Egypt
,
Mohammed LabanFaculty of Medicine, Department of Obstetrics and Gynecology, Ain Shams University, Cairo, EgyptCorrespondence[email protected]
,
Ahmed M. IbrahimFaculty of Medicine, Department of Obstetrics and Gynecology, Ain Shams University, Cairo, Egypt
,
Wafaa U. AhmedFaculty of Medicine, Department of Obstetrics and Gynecology, Ain Shams University, Cairo, Egypt
&
Ayman A. Abou ElnoorFaculty of Medicine, Department of Obstetrics and Gynecology, Ain Shams University, Cairo, Egypt
Pages 850-854 | Received 17 Dec 2014, Accepted 18 Feb 2015, Published online: 30 Mar 2015

References

  • von Hertzen H, Piaggio G, Wojdyla D. Comparison of vaginal and sublingual misoprostol for second trimester abortion: randomized controlled equivalence trial. Hum Reprod 2009;24:106–12
  • Lalitkumar S, Bygdeman M, Gemzell-Danielsson K. Mid-trimester induced abortion: a review. Hum Reprod Update 2007;13:37–52
  • Shabana A, Salah H, Kandil M, et al. Termination of mid-trimester pregnancies: misoprostol versus concurrent weighted Foley catheter and misoprostol. F1000Research 2012;1:36–40
  • Sundaram S, Diaz JP, Gonzalez-Quintero VH, Verma U. Rectal misoprostol vs 15-methyl prostaglandin F2for retained placenta after second trimester delivery. Am J Obstet Gynecol 2009;200:e24–6
  • Leader J, Bujnovsky M, Carlan S. Effect of oral misoprostol after second-trimester delivery: a randomized, blinded study. Obstet Gynecol 2002;100:689–94
  • Dickinson J, Doherty D. Optimization of third-stage management after second-trimester medical pregnancy termination. Am J Obstet Gynecol 2009b;201:303.e1–7
  • Carbonell JL, Torres A, Reyes R, et al. Second-trimester pregnancy termination with 600-g vs. 400-g vaginal misoprostol and systematic curettage postexpulsion: a randomized trial. Contraception 2008;77:50–5
  • Kent A. Carbetocin at cesarean delivery. Rev Obstet Gynecol 20103;3:1–123
  • Attilakos G, Psaroudakis D, Ash J. Carbetocin versus oxytocin for the prevention of postpartum haemorrhage following caesarean section: the results of a double-blind randomised trial. BJOG 2010;117:929–36
  • Higgins L, Mechery J, Tomlinson AJ. Does carbetocin for prevention of postpartum haemorrhage at caesarean section provide clinical or financial benefit compared with oxytocin? J Obstet Gynaecol 2011;31:732–9
  • Larciprete G, Montagnoli C, Frigo M, et al. Carbetocin versus oxytocin in caesarean section with high risk of post-partum haemorrhage. J Prenat Med 2013;7:12–18
  • Boucher M, Nimrod CA, Tawagi GF, et al. Comparison of carbetocin and oxytocin for the prevention of postpartum haemorrhage following vaginal delivery: a double-blind randomized trial. J Obstet Gynecol Can 2004;26:481–8
  • World Health organization: safe abortion: technical and policy guidance for health systems, 2nd ed. Geneva, Switzerland: WHO Library Cataloguing-in-Publication Data; 2012
  • Anshu G. A comparative study of methylergonovine and 15-methyl prostaglandin F2α in active management of third stage of labor. Obstet Gynecol Sci 2013;56:301–6
  • Carlan SJ, Gushwa JP, O’Brien WF, Vu T. Effect of intramuscular 15-methyl prostaglandin F2. Obstet Gynecol 1997;89:5–9
  • Borruto F, Treisser A, Comparetto C. Utilization of carbetocin for prevention of postpartum hemorrhage after cesarean section: a randomized clinical trial. Arch Gynecol Obstet 2009;280:707–12
  • Gizzo S, Patrelli T, Di Gangi S, et al. Which uterotonic is better to prevent the postpartum hemorrhage? Latest news in terms of clinical efficacy, side effects, and contraindications: a systematic review. Reprod Sci 2013;20:1011–19

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.